PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Total Current Liabilities for 7 consecutive years, with $64.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 29.1% year-over-year to $64.2 million in Q2 2026; TTM through Jun 2026 was $64.2 million, a 29.1% increase from a year earlier, with the FY2025 full-year figure at $65.8 million, up 23.83% from the prior year.
• Total Current Liabilities was $64.2 million for Q2 2026 at PROCEPT BioRobotics, up from $63.6 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $65.8 million in Q4 2025 and troughed at $14.8 million in Q1 2022.
• A 5-year average of $43.9 million and a median of $44.4 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 120.26% in 2023 and gained 0.47% in 2025, its largest moves.
• Over 5 years, Total Current Liabilities stood at $35.3 million in 2022, then soared by 30.14% to $45.9 million in 2023, then gained by 15.69% to $53.1 million in 2024, then grew by 23.83% to $65.8 million in 2025, then decreased by 2.43% to $64.2 million in 2026.
• The last three Total Current Liabilities figures came in at $64.2 million (Q2 2026), $63.6 million (Q1 2026), and $65.8 million (Q4 2025), per Business Quant data.